According to filings with the U.S. Securities and Exchange Commission, Curadel Surgical Innovations is raising up to $8,500,000.00 in new funding. Sources indicate that as part of senior management President, John Frangioni played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Curadel Surgical Innovations
Curadel, LLC is a research and development (R&D) company specializing in novel devices and drugs for the treatment of cancer and other diseases. Its core ideology is We exist to alleviate suffering and its team has been carefully selected to work as a collegial and coherent group to solving some of the most difficult problems in medicine and surgery. Curadel has a particular expertise in near-infrared (NIR) fluorescence optical imaging and it scientists and engineers are responsible for many of the recent advances in the field. Curadel was founded by John V. Frangioni, M.D., Ph.D., Professor of Medicine and Professor of Radiology (currently part-time) at Harvard Medical School.

To learn more about Curadel Surgical Innovations, visit http://www.curadel.com/
Curadel Surgical Innovations Linkedin Page: https://www.linkedin.com/company/curadelpharma/

Contact:
John Frangioni, President
508-305-2355

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.